WuXi RSD Biology provides validated discovery assays, including in vitro assays (HTS, SAR screening support, compound selectivity and early safety profiling, and cancer cell panel profiling) and in vivo disease models in cardiovascular, CNS, respiratory, metabolic and infectious diseases. Founded in 2008, we have multiple function teams of ~400 scientists, including 11% PhD, 55% MSc, and led by 10 seasoned scientific leaders with an average of 15 years of R&D experience in the US, Canada, and UK.